Cargando…
In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers
A growing body of evidence suggests that a loss of chromosome 9 open reading frame 72 (C9ORF72) expression, formation of dipeptide-repeat proteins, and generation of RNA foci contribute to disease pathogenesis in amyotrophic lateral sclerosis and frontotemporal dementia. Although the levels of C9ORF...
Autores principales: | DeJesus-Hernandez, Mariely, Finch, NiCole A., Wang, Xue, Gendron, Tania F., Bieniek, Kevin F., Heckman, Michael G., Vasilevich, Aliaksei, Murray, Melissa E., Rousseau, Linda, Weesner, Rachael, Lucido, Anthony, Parsons, Meeia, Chew, Jeannie, Josephs, Keith A., Parisi, Joseph E., Knopman, David S., Petersen, Ronald C., Boeve, Bradley F., Graff-Radford, Neill R., de Boer, Jan, Asmann, Yan W., Petrucelli, Leonard, Boylan, Kevin B., Dickson, Dennis W., van Blitterswijk, Marka, Rademakers, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508036/ https://www.ncbi.nlm.nih.gov/pubmed/28508101 http://dx.doi.org/10.1007/s00401-017-1725-7 |
Ejemplares similares
-
Abnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriers
por: Finch, NiCole A., et al.
Publicado: (2017) -
Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS
por: Gendron, Tania F., et al.
Publicado: (2013) -
Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers
por: Dickson, Dennis W., et al.
Publicado: (2019) -
Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations
por: Pottier, Cyril, et al.
Publicado: (2021) -
Long-read targeted sequencing uncovers clinicopathological associations for C9orf72-linked diseases
por: DeJesus-Hernandez, Mariely, et al.
Publicado: (2021)